35 results
8-K
EX-99.1
NUVL
Nuvalent Inc - Ordinary Shares
27 Feb 24
Nuvalent Highlights Pipeline Progress, Reiterates Key Anticipated Milestones and Reports Fourth Quarter and Full Year 2023 Financial Results
6:38am
of increasing responsibility in human resources at Gamida Cell, Ltd, Sage Therapeutics, Inc, and Infinity Pharmaceuticals. Mr. Metivier holds an MBA from
8-K
EX-99.1
h679o3p43aq
14 Nov 23
Nuvalent Highlights Corporate and Pipeline Achievements and Reports Third Quarter
6:45am
8-K
EX-1.1
sv6 768e559stl6bs8
17 Oct 23
Nuvalent Announces Pricing of Public Offering of Common Stock
4:07pm
424B5
irj3b43 14m55d8
17 Oct 23
Prospectus supplement for primary offering
4:05pm
424B5
b7qzhvh
16 Oct 23
Prospectus supplement for primary offering
7:39am
PRE 14A
fthygqnml9z
13 Apr 23
Preliminary proxy
4:30pm
8-K
EX-1.1
7w0pmw1
1 Nov 22
Nuvalent Announces Pricing of Public Offering of Common Stock
5:19pm
8-K
EX-1.2
z9oq6ivtwa
1 Nov 22
Nuvalent Announces Pricing of Public Offering of Common Stock
5:19pm
424B5
zjyne0sqf3lscmdcvka5
1 Nov 22
Prospectus supplement for primary offering
5:17pm
424B5
l3yhlimuoxpop86v
31 Oct 22
Prospectus supplement for primary offering
7:21am
424B5
z0b9hbmlnbo zb
17 Aug 22
Prospectus supplement for primary offering
4:23pm
S-3
EX-1.2
zg2rdkq
10 Aug 22
Shelf registration
8:35am
S-3
EX-4.5
mxszz 8fyv
10 Aug 22
Shelf registration
8:35am